Recent developments in natural biopolymer based drug delivery systems

T Fazal, BN Murtaza, M Shah, S Iqbal, M Rehman… - RSC …, 2023 - pubs.rsc.org
Targeted delivery of drug molecules to diseased sites is a great challenge in pharmaceutical
and biomedical sciences. Fabrication of drug delivery systems (DDS) to target and/or …

Metallic nanoparticles as drug delivery system for the treatment of cancer

N Desai, M Momin, T Khan, S Gharat… - Expert opinion on …, 2021 - Taylor & Francis
Introduction The targeted delivery of anticancer agents to tumor is a major challenge
because most of the drugs show off-target effect resulting in nonspecific cell death …

A review of small molecules and drug delivery applications using gold and iron nanoparticles

H Jahangirian, K Kalantari, Z Izadiyan… - International journal …, 2019 - Taylor & Francis
Conventional cancer treatment techniques show several limitations including low or no
specificity and consequently a low efficacy in discriminating between cancer cells and …

Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer

P Yadav, SV Ambudkar, N Rajendra Prasad - Journal of …, 2022 - Springer
Cancer often develops multidrug resistance (MDR) when cancer cells become resistant to
numerous structurally and functionally different chemotherapeutic agents. MDR is …

Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer

J Halder, D Pradhan, B Kar, G Ghosh, G Rath - … , Biology and Medicine, 2022 - Elsevier
Multidrug resistance (MDR) in cancer chemotherapy is a growing concern for medical
practitioners. P-glycoprotein (P-gp) overexpression is one of the major reasons for multidrug …

Role of multidrug resistance-associated proteins in cancer therapeutics: past, present, and future perspectives

A Elfadadny, HM El-Husseiny, A Abugomaa… - … Science and Pollution …, 2021 - Springer
Cancer, a major public health problem, is one of the world's top leading causes of death.
Common treatments for cancer include cytotoxic chemotherapy, surgery, targeted drugs …

Effect of cellular and microenvironmental multidrug resistance on tumor-targeted drug delivery in triple-negative breast cancer

O Tezcan, AS Elshafei, K Benderski, E Rama… - Journal of Controlled …, 2023 - Elsevier
Multidrug resistance (MDR) reduces the efficacy of chemotherapy. Besides inducing the
expression of drug efflux pumps, chemotherapy treatment alters the composition of the tumor …

Epigallocatechin gallate-gold nanoparticles exhibit superior antitumor activity compared to conventional gold nanoparticles: Potential synergistic interactions

SR Chavva, SK Deshmukh, R Kanchanapally, N Tyagi… - Nanomaterials, 2019 - mdpi.com
Epigallocatechin gallate (EGCG) possesses significant antitumor activity and binds to
laminin receptors, overexpressed on cancer cells, with high affinity. Gold nanoparticles …

MDR in cancer: Addressing the underlying cellular alterations with the use of nanocarriers

MS Singh, SN Tammam, MAS Boushehri… - Pharmacological …, 2017 - Elsevier
Multidrug resistance (MDR) is associated with a wide range of pathological changes at
different cellular and intracellular levels. Nanoparticles (NPs) have been extensively …

Gold nanoparticle‑mediated delivery of paclitaxel and nucleic acids for cancer therapy

Z Wang, J Dong, Q Zhao, Y Ying… - Molecular …, 2020 - spandidos-publications.com
Paclitaxel is a potent antineoplastic agent, but poor solubility and resistance have limited its
use. Gold nanoparticles (AuNPs) are widely studied as drug carriers because they can be …